0
0 (0%)
Cnbx Pharmaceuticals Inc. [CNBX]
Source:
Company Overview
Cnbx Pharmaceuticals Inc. is a clinical-stage company specializing inthe discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment ofcancer.
| Country | United States |
| Headquarters | bethesda, maryland |
| Phone Number | 877-424-2429 |
| Industry | manufacturing |
| CEO | Eyal Barad, Director |
| Website | www.cnbxpharma.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0 |
| Operating Profit | $-0 |
| Net Income | $-0 |
| Net Cash | $-0 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -128% |
| Profit as % of Stockholder Equity | 1.4% |
Management Effectiveness
| Return on Equity | 1.4% |
| Return on Assets | -154% |
| Turnover Ratio | |
| EBITA | $-0 |
Balance Sheet and Cash Flow Measures
| Total Assets | $0 |
| Total Liabilities | $2.5 |
| Operating Cash Flow | $-0 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $0 |
